Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Our take

Compare TelosRX using the full selected term and early-exit calculation. Included monitoring may be useful, but $125 alone is not enough to establish the cost of starting or stopping.

From $125/mo equivalent; full term unconfirmedAdvertised $125/month minimum depends on plan length
Subcutaneous injectionFormat offered
Prescription requiredSubject to clinical evaluation

What stands out

  • Quarterly labs advertised as included
  • Clinical practice identified
  • Portal cancellation and messaging described

What to weigh

  • Minimum price lacks a complete public plan total
  • Early cancellation can trigger repricing
  • Orders become nonrefundable at pharmacy transmission

The minimum headline needs a complete quote

TelosRX advertises sermorelin as low as $125 per month and says the price depends on plan length. The reviewed page does not show enough term-by-term information to establish the complete charge attached to that minimum. We have therefore left the comparison price unconfirmed rather than presenting $125 as a one-month purchase.

Request the chosen term, the full amount due now, the future payment schedule and the applicable shorter-plan rates. Those details become especially important if you later stop a discounted plan. A low equivalent can be useful for comparing a long commitment, but it is not a complete description of how much a new patient must pay or what flexibility actually costs.

Early cancellation can change the rate

The product page says cancellation has no penalties. The shipping and returns policy adds a material qualification: received months on a discounted three-, six- or twelve-month plan are repriced to the shortest plan covering the time enrolled, and the difference is charged when canceling early. Future months are not charged.

That adjustment may be described differently from a cancellation fee, but it still affects the amount paid. Ask for an example using the exact plan you are considering, including what happens if the clinician recommends stopping. Without the shorter-plan rate, a patient cannot calculate the financial effect of leaving early. Keep the quoted calculation with the enrollment agreement rather than relying only on the simpler promotional wording.

Included monitoring deserves a closer look

TelosRX’s sermorelin page describes subcutaneous injections, quarterly labs and unlimited care-team messaging. It identifies Arora Health & Aesthetics as the clinical provider and distinguishes the storefront’s administrative role from medical care. These are useful details for readers comparing more than medication prices.

Ask which tests are included, how samples are collected and who reviews the results with you. Quarterly testing is a schedule, not a description of every clinical question that may need attention between scheduled reviews. Also clarify whether messaging access includes a promised response time and when a video visit would be arranged. The relevant comparison is the care you can actually use, especially if another clinician is already managing related concerns.

The refund cutoff comes before shipment

TelosRX’s policy makes an order nonrefundable after the prescription is approved and transmitted to a pharmacy, even if the medication has not shipped. It requests reports of damaged, leaking or incomplete deliveries within forty-eight hours and describes replacement when warranted. The policy says clinical ineligibility receives a full refund when no prescription has been issued or transmitted.

This makes the order’s processing stage important. If an intake contains an error or your circumstances change, contact the service promptly rather than waiting for a shipping notice. Keep packaging and order details when raising a delivery concern, and ask the dispensing pharmacy about medication condition before using a questionable shipment. Fast processing can shorten the practical window for correcting an order.

Our assessment of TelosRX

TelosRX’s advertised laboratory inclusion and named clinical practice make it worth a closer comparison. The limiting factor is commercial clarity: a minimum monthly equivalent, undisclosed complete plan pricing and an early-exit adjustment require more explanation before value can be judged. I would obtain that explanation before selecting a longer term.

The provider describes its medication as compounded and not FDA-approved. Its recovery and body-composition claims should be discussed as treatment claims with uncertainties, not promised outcomes. This October 2026 review is based on public pages, not firsthand enrollment or care. Confirm state-specific formulation availability and the assigned pharmacy as well as the price; broad national access language does not guarantee every preparation can be dispensed everywhere.

Common questions

Can I buy one month for $125?

The public page says as low as $125 per month and that price depends on plan length. It does not establish a one-month $125 purchase.

Are follow-up labs included?

The sermorelin page advertises quarterly labs with ongoing messaging. Confirm the test panel, collection method and timing.

Does early cancellation cost anything?

The policy says already received months on discounted longer plans are repriced to the shortest applicable plan, with the difference charged at cancellation.

Explore TelosRX

See the current offer and decide whether you want to start a consultation.

Visit TelosRX

Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Sources & further reading

Provider prices and terms may change.

  1. TelosRX website
  2. FDA: Understanding the risks of compounded drugs
  3. Endocrine Society: Hormones and Aging scientific statement